{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:38:38Z","timestamp":1774535918522,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.cgh.2016.05.039","type":"journal-article","created":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T13:27:20Z","timestamp":1466342840000},"page":"1647-1656.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B"],"prefix":"10.1016","volume":"14","author":[{"given":"Hye Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oidov","family":"Baatarkhuu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Hyub","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.05.039_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.05.039_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2016.05.039_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"Management of chronic hepatitis B virus infection","volume":"57","author":"EASL clinical practice guidelines","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2016.05.039_bib5","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1517\/14656566.7.13.1835","article-title":"Lamivudine treatment in patients with chronic hepatitis B and cirrhosis","volume":"7","author":"Hache","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cgh.2016.05.039_bib6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2012.01.044","article-title":"Effectiveness of hepatitis B treatment in clinical practice","volume":"142","author":"Scaglione","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.05.039_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.22841","article-title":"Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy","volume":"49","author":"Tenney","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.05.039_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.05.039_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2014.02.033","article-title":"Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine","volume":"147","author":"Lim","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.05.039_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jvh.12283","article-title":"Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet. Greece cohort","volume":"22","author":"Papatheodoridis","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2016.05.039_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1872-034X.2011.00785.x","article-title":"Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine","volume":"41","author":"Kobashi","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2016.05.039_bib12","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1053\/j.gastro.2011.02.058","article-title":"Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C","volume":"140","author":"Vergniol","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.05.039_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.24121","article-title":"Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)","volume":"53","author":"Jung","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.05.039_bib14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ajg.2014.157","article-title":"Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy","volume":"109","author":"Lee","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.05.039_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3350\/cmh.2014.20.3.223","article-title":"Risk stratification of HBV infection in Asia-Pacific region","volume":"20","author":"Kao","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3350\/cmh.2015.21.3.200","article-title":"Personalized management of cirrhosis by non-invasive tests of liver fibrosis","volume":"21","author":"Wong","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib17","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s10620-014-3488-5","article-title":"Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients","volume":"60","author":"Wong","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.05.039_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3350\/cmh.2012.18.2.109","article-title":"KASL clinical practice guidelines: management of chronic hepatitis B","volume":"18","author":"Korean Association for the Study of the Liver","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/kjhep.2012.18.1.1","article-title":"Revision and update on clinical practice guideline for liver cirrhosis","volume":"18","author":"Suk","year":"2012","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: a meta-analysis","volume":"134","author":"Friedrich-Rust","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.05.039_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27735","article-title":"Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis","volume":"61","author":"Kim","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.05.039_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.05.039_bib23","series-title":"Survival analysis: techniques for censored and truncated data","author":"Klein","year":"2005"},{"key":"10.1016\/j.cgh.2016.05.039_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3350\/cmh.2016.22.1.18","article-title":"KASL clinical practice guidelines: management of chronic hepatitis B","volume":"22","author":"Korean Association for the Study of the Liver (KASL)","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2015.21.1.1","article-title":"Personalized treatment of hepatitis B","volume":"21","author":"Lok","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.20464","article-title":"Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection","volume":"40","author":"van Bommel","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.05.039_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jhep.2013.06.007","article-title":"Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment","volume":"59","author":"Seto","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","author":"Papatheodoridis","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.05.039_bib29","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/gut.2010.221846","volume":"60","author":"Papatheodoridis","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.05.039_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3851\/IMP1982","article-title":"HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B","volume":"16","author":"Kim","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cgh.2016.05.039_bib31","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.28115","article-title":"Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy","volume":"62","author":"Jung","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.05.039_bib32","doi-asserted-by":"crossref","first-page":"e36676","DOI":"10.1371\/journal.pone.0036676","article-title":"Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516303032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516303032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:20:01Z","timestamp":1761542401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516303032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1542356516303032"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.05.039","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the AGA Institute","name":"copyright","label":"Copyright"}]}}